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STEM CELLS AND REGENERATION RESEARCH ARTICLE
The transcription factor E2A drives neural differentiation in
pluripotent cells
Chandrika Rao1, Mattias Malaguti1, John O. Mason2,3 and Sally Lowell1,*
ABSTRACT
The intrinsic mechanisms that link extracellular signalling to the onset
of neural differentiation are not well understood. In pluripotent mouse
cells, BMP blocks entry into the neural lineage via transcriptional
upregulation of inhibitor of differentiation (Id) factors. We have
previously identified the major binding partner of Id proteins in
pluripotent cells as the basic helix-loop-helix (bHLH) transcription
factor (TF) E2A. Id1 can prevent E2A from forming heterodimers with
bHLH TFs or from forming homodimers. Here, we show that
overexpression of a forced E2A homodimer is sufficient to drive
robust neural commitment in pluripotent cells, even under non-
permissive conditions. Conversely, we find that E2A null cells display
a defect in their neural differentiation capacity. E2A acts as an
upstream activator of neural lineage genes, including Sox1 and
Foxd4, and as a repressor of Nodal signalling. Our results suggest a
crucial role for E2A in establishing neural lineage commitment in
pluripotent cells.
KEY WORDS: E2A, BHLH, Neural development, Pluripotent
INTRODUCTION
Following the establishment of the primary germ layers during
gastrulation, the embryonic neural plate is specified from the
anterior ectoderm at approximately embryonic day (E)7.5 in a
process known as neural induction (Tam and Zhou, 1996).
Pluripotent embryonic stem cells (ESCs) recapitulate central
features of this process when differentiated in culture (Ying et al.,
2003b), providing a useful system in which to study the mechanisms
guiding these initial cell fate decisions during development.
Although the key extracellular signalling pathways that inhibit
neural lineage commitment have long been established, less
progress has been made in identifying the downstream effectors
of these pathways. In particular, inhibition of BMP signalling is
crucial for the establishment of the neuroectoderm (Harland, 2000;
Di-Gregorio et al., 2007). The finding that BMP signalling inhibits
neural differentiation via transcriptional upregulation of Id1 (Ying
et al., 2003a) provides compelling evidence that Id proteins block
the activity of a factor that would otherwise trigger the onset of
neural commitment.
Id proteins lack a DNA-binding domain and function primarily as
dominant-negative inhibitors of basic helix-loop-helix (bHLH)
transcription factors (TFs), binding to and preventing them from
forming functional dimers (Norton, 2000). It has previously been
reported that Id1 indirectly inhibits the activity of the bHLH TF
Tcf15. However, Tcf15 appears to play a role in general priming for
differentiation by enabling morphological changes, and does not
have a specific instructive role in neural commitment (Davies et al.,
2013; Lin et al., 2019 preprint). We have also found that E-cadherin
(Cdh1) acts downstream of BMP to help suppress neural
commitment (Malaguti et al., 2013) but it is not known if or how
Id1 is mechanistically linked with this process. Id1 is also reported
to block the activity of the epigenetic regulator Zrf1, preventing
derepression of neural genes in ESCs (Aloia et al., 2015). Zrf1
overexpression alone, however, is not sufficient to drive expression
of these genes, suggesting a requirement for additional factors to
initiate neural differentiation in ESCs.
We have previously identified the alternatively spliced E2A gene
products E47 and E12 as the main binding partners of Id1 in ESCs
(Davies et al., 2013). E2A (also known as Tcf3 – not to be confused
with Tcf7L1, which is also commonly known as Tcf3) belongs to
the E-protein family of bHLH TFs, which also includes HEB
(Tcf12) and E2-2 (Tcf4). E2A is able to regulate the transcription of
its target genes either by homodimerisation or by heterodimerisation
with class II bHLH TFs, such as the proneural factors Ascl1 and
neurogenin1/2 (Murre et al., 1989). Although E2A-bHLH
heterodimers are well-established regulators of several fate
determination processes, including neuronal subtype specification
(Imayoshi and Kageyama, 2014), E2A homodimers have only
been identified to function in the context of B-cell development
(Shen and Kadesch, 1995), and it is not currently known whether
this homodimer could also operate to control cell fate in other
contexts.
E2A knockout mouse models have thus far failed to identify any
overt gastrulation defects, with a failure of B-cell specification being
the only major phenotype described to date (Bain et al., 1994;
Zhuang et al., 1994). More recent analysis of these models,
however, has noted that knockout mice have a significantly reduced
brain size compared with their wild-type counterparts (Ravanpay
and Olson, 2008), suggesting that a more in-depth investigation into
the role of E2A during the earlier stages of development might be
required to uncover subtle neural differentiation defects. In Xenopus
embryos, loss of E2A has been associated with the inhibition of
gastrulation (Yoon et al., 2011). Additionally, E2A and HEB have
been shown to be co-factors of the Nodal signalling pathway, both
in human ESCs and in Xenopus (Yoon et al., 2011), with E2A
playing a dual role to directly repress the Nodal target gene lefty
during mesendoderm specification in Xenopus, while also driving
the expression of dorsal cell fate genes (Wills and Baker, 2015).
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In this study, we investigate a potential role for E2A homodimers
in neural fate commitment. We first set out to characterise the
expression of E2A during early neural differentiation by the
generation of an endogenously tagged E2A-V5 ESC line. Using a
gain-of-function approach, we find that overexpression of a forced
E2A homodimer, but not monomer, is sufficient to drive the neural
commitment of ESCs, even in the presence of serum, providing
novel mechanistic insight into the molecular events unfolding
downstream of Id1 during neural commitment. CRISPR/Cas9
targeting of E2A and HEB loci to generate single and double
E-protein knockout ESC lines, additionally reveals that E-protein
deficiency compromises the neural differentiation ability of
ESCs. RNA-sequencing (RNA-seq) analysis further confirmed
that E2A is positioned upstream of the expression of several neural
lineage-associated genes, including Sox1 and Foxd4, and might
additionally play a role in suppressing Nodal signalling during
neural differentiation. We therefore propose that the E2A
homodimer is a key intrinsic regulator of neural fate commitment
in pluripotent ESCs.
RESULTS
E2A is expressed heterogeneously in pluripotent ESCs and
throughout neural differentiation
To characterise the expression of E2A during early neural
differentiation we first examined the temporal expression of E2A
mRNA in ESCs, plated under standard neural monolayer conditions
(Ying et al., 2003b), by qRT-PCR. Sox1 is the earliest specific
marker of the neuroectoderm in mice (Pevny et al., 1998) and is
therefore used to follow neural fate acquisition in ESCs. In line with
previously published data (Ying et al., 2003b; Aiba et al., 2009), we
observed that expression of the negative regulator of E2A, Id1, is
rapidly downregulated at the onset of differentiation (Fig. 1A). E2A
expression, however, remains fairly constant during this initial
period. As E2A is regulated by Id1 at the protein level, rather than
the transcriptional level, we generated an endogenously tagged ESC
line (Fig. 1B) using CRISPR/Cas9 targeting to follow the
expression of E2A protein during differentiation. Based on a
strategy previously developed to tag neural stem cells with high
efficiency (Dewari et al., 2018), guide RNA (sgRNA) was designed
to cut proximally to the stop codon in the 3′UTRof E2A (Fig. S1A),
and was co-transfected into wild-type ESCs with recombinant Cas9
protein (rCas9) and a single-stranded donor DNA template (ssODN)
encoding the V5 tag flanked by homology arms (Fig. S1B). Clonal
lines were isolated from the bulk population and individual clones
were subsequently screened by PCR genotyping (Fig. S1C), and
analysed by immunostaining (Fig. 1D) for the V5 fusion protein.
Sanger sequencing confirmed the error-free insertion of V5 into the
C-terminus of the E2A locus by homology-directed repair (Fig. S1D).
We monitored the expression of the endogenously tagged E2A
protein during neural differentiation using an antibody directed
against the V5 tag for western blot analysis. This showed that E2A
protein is expressed stably across the timecourse, with a slight
increase in expression as cells exit pluripotency at day 1 (Fig. 1C),
mirroring the pattern of E2A mRNA expression (Fig. 1A).
Immunostaining of E2A-V5 cells revealed that E2A expression is
heterogeneous in pluripotent ESCs on the single cell level in
leukaemia inhibitory factor (LIF)/serum culture (Fig. 1D). When
E2A-V5 ESCs are plated under neural differentiation conditions,
E2A expression remains high and retains a heterogeneous
expression pattern as cells exit the pluripotent state (Oct4+Sox2−),
and progressively commit to the neural lineage (Oct4−Sox2+)
(Fig. 1E).
E2A homodimers promote neural fate commitment under
self-renewal conditions
Having observed that E2A expression is dynamic during the early
stages of differentiation, we next wanted to address whether E2A
could play an instructive role during this cell fate transition. To
determine whether E2A is sufficient to promote neural
differentiation, we generated doxycycline-inducible ESC lines to
overexpress either monomeric E2A or a forced E2A homodimer in
which two E2A sequences are tethered by a flexible amino acid
linker (Fig. 2A). This forced dimer strategy not only renders E2A
more resistant to inhibition by Id but also favours the formation of
E2A homodimers due to the physical proximity of the two
molecules (Neuhold and Wold, 1993). FLAG-tagged E47
monomer or forced homodimer constructs were placed under the
control of a tetracycline-response element and introduced into ESCs
containing an inducible cassette exchange locus upstream of the
HPRT gene (Iacovino et al., 2013). When expression of the two
E2A constructs was induced by doxycycline (dox) in LIF/serum
culture, conditions that are inhibitory for neural differentiation, we
found that overexpression of the forced E2A homodimer, but not the
monomer, elicited a robust upregulation of Sox1 (Fig. 2B,D;
Fig. S2). Coincident with the peak of Sox1 expression on day 2, we
also observed that cells overexpressing the homodimer lost the
domed colony morphology typical of ESCs, and instead spread out
to cover the dish. We evaluated that 34% of cells were Sox1+Oct4−
after 4 days of culture (Fig. 2C), which was indicative of neural
commitment. qRT-PCR analysis revealed that forced expression of
E2A homodimers also enhanced the expression of the neural marker
N-cadherin (Cdh2), downregulated Cdh1 expression, and caused a
transient upregulation of the epiblast marker Fgf5 (Fig. 2D).
Overexpression of both the monomeric and forced homodimer
forms of E2A also appeared to stimulate a feedback response,
causing upregulation of the negative regulator of E2A, Id1, as has
been observed previously (Bhattacharya and Baker, 2011).
It has been reported that E2A homodimers are stabilised by an
intermolecular disulphide bond formed between cysteine residues
located in helix one of the bHLH domain (Benezra, 1994) (Fig.
S3A). To confirm that it was specifically E2A homodimers, and not
E2A-bHLH heterodimers, that are driving neural commitment in
ESCs, we generated E2A forced dimer cell lines in which cysteine-
570 is mutated to alanine in both E2A sequences (Fig. S3B) in an
attempt to disrupt the formation of this covalent bond and therefore
destabilise homodimer formation. These mutants are reported to
retain heterodimerisation ability (Benezra, 1994). Two such mutant
lines, C570A-1 and C570A-9, were stimulated with dox in LIF/
serum for 2 days. qRT-PCR analysis of both mutant and control
inducible lines showed that although C570A mutants were still able
to upregulate Id1, they were no longer able to upregulate expression
of Sox1 (Fig. 2E), suggesting that this single amino acid substitution
did, indeed, ablate the ability of E2A to drive differentiation.
Western blot analysis of monomeric and forced E2A homodimer
constructs demonstrated that expression of the forced homodimer
was considerably lower than that of the monomer (Fig. S3C), ruling
out the possibility that enhanced activity of the forced homodimer
is explained simply by increased protein stability or the
accumulation of E2A. C570A mutant lines appeared to express
E2A at slightly lower levels than their wild-type homodimer
counterparts. Taken together, these findings demonstrate that
overexpression of E2A homodimers is sufficient to override the
potent inhibitory effect of serum in non-permissive culture
conditions, consistent with a role for E2A homodimers in
initiating neural fate commitment.
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E2A−/− and E2A−/−HEB−/− knockout ESCs display
compromised neural lineage commitment ability
We next set out to evaluate whether E2A is necessary for neural
differentiation. To generate E2A knockout ESCs, we used CRISPR/
Cas9 to target exon 3 of the E2A gene locus, disrupting both E12
and E47 transcripts. Owing to the high degree of functional
compensation observed between E-protein family members
(Zhuang et al., 1998), which could mask potential differentiation
phenotypes, we also generated E2A−/−HEB−/− double E-protein
knockout ESC lines by using a similar strategy to target exon 9 of
HEB in the E2A−/− cell line (Fig. S4A). Targeted lines were
validated by western blot analysis and sequencing of the targeted
loci (Fig. S4B-F).
To first determine whether E-protein knockout cells retain
characteristic features of pluripotent stem cells, we assessed cell
morphology and gene expression in LIF/serum conditions. Colony
morphology was indistinguishable between the parental E2A-V5
cell line and E2A−/− and E2A−/−HEB−/− cells, and immunostaining
showed similar levels of expression of the pluripotency markers
Oct4 and Nanog between knockout and parental cells (Fig. 3A),
indicating normal self-renewal. qRT-PCR analysis of pluripotency
and lineage markers in LIF/serum further confirmed that there were
no differences in expression levels between parental and knockout
cell lines (Fig. 3B).
We next examined the ability of the knockout cells to differentiate
under standard neural monolayer conditions. qRT-PCR analyses
showed that, compared with controls, E2A−/− and E2A−/−HEB−/−
cells were unable to robustly upregulate markers of neural
differentiation, including Sox1, Foxd4 and Pax3 (Fig. 3B;
Fig. S5). Furthermore, although knockout cells were able to
Fig. 1. Endogenous tagging reveals E2A is expressed heterogeneously in pluripotent cells. (A) qRT-PCR analysis of pluripotent ESCs plated under
standard neural differentiation conditions. Expression values are normalised to the housekeeping gene Sdha. Data are mean±s.d. n=3 biological replicates.
(B) Schematic of wild-type (WT) and tagged E2A locus. The V5 epitope tag was knocked-in at the 3′ UTR of the endogenous E2A locus. The V5 tag is shown in
green and the stop codon in red. (C) Western blot analysis of E2A-V5 cells during neural differentiation. β-Tubulin was analysed as a loading control.
(D) Immunostaining of parental wild-type ESCs and epitope-tagged E2A-V5 ESCs. Cells co-stained for the V5 tag, the pluripotency marker Nanog and
nuclear marker DAPI. (E) Immunostaining of E2A-V5 cells from days 2 to 5 of neural differentiation. Cells were stained for Oct4 and Sox2 to enable identification
of cells committing to the neural lineage (Oct4−/Sox2+). Scale bars: 30 µm.
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downregulate expression of the naïve pluripotency marker Nanog,
they maintained comparably high expression of the epiblast markers
Oct4 and Fgf5. Immunostaining of differentiation cultures for Sox1,
Oct4 (Fig. 3C) and the marker of immature neurons, Tuj1 (Fig. 3D),
further supported the gene expression data. Interestingly, we also
observed that the disruption of E-protein expression resulted in an
upregulation of the mesendodermal lineage markers, T (brachyury)
andEomes (Fig. 3B,D), as well as re-expression ofNanog, suggesting
that these cells were beginning to adopt an identity more similar to the
proximal epiblast, despite being cultured under neural differentiation
conditions. Furthermore, we noted that both the neural differentiation
defect and the upregulation of mesendodermal markers were more
pronounced when HEB was deleted in addition to E2A, indicating
that HEB is able to functionally compensate for E2A, to a limited
extent, in this context. Taken together with the overexpression data,
these findings suggest that E2A is both sufficient and required for
efficient neural differentiation of ESCs.
Identification of early E2A response genes
Having identified a novel role for E2A homodimers in driving the
neural differentiation of ESCs, we next sought to identify the
downstream targets of E2A in this process. We have previously
Fig. 2. An E2A forced homodimer drives Sox1 expression under self-renewal conditions. (A) Schematic representation of monomeric E2A and forced
E2A homodimer constructs. (B) Immunostaining of inducible E2A forced homodimers and monomers cultured in LIF/serum+dox. Scale bars: 30 µm.
(C) Quantification of immunostaining for E2A monomers and homodimers cultured in LIF/serum+dox. A range of 500 to 5000 cells were manually scored for
each timepoint. (D) qRT-PCR analysis of dox-inducible overexpression of E2A monomers and homodimers in LIF/serum. Expression is normalised to day 0
minus dox controls. (E) qRT-PCR analysis of two mutant forced homodimer clones (C570A-1 and C570A-9) induced in LIF/serum+dox. Expression values
are normalised to the housekeeping gene Sdha. Data are mean±s.d., n=3 biological replicates. *P<0.05, two-tailed paired Student’s t-test.
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reported that BMP blocks neural differentiation by maintaining
E-cadherin (Malaguti et al., 2013), and others have reported that
E2A is a direct transcriptional repressor of E-cadherin (Pérez-
Moreno et al., 2001). Combined with our earlier observation that
forced homodimer expression causes a downregulation of
E-cadherin mRNA expression (Fig. 2B), we hypothesised that
E2A homodimers may also repress E-cadherin protein expression to
enable neural differentiation. However, contrary to this hypothesis,
we detected no significant downregulation of E-cadherin protein in
response to the induction of E2A homodimers before the expression
of Sox1 (Fig. S6A). Our findings do not exclude the possibility that
E-cadherin is a transcriptional target of E2A in pluripotent cells but
they do suggest that E-cadherin is unlikely to mediate the effects of
E2A on neural differentiation.
To identify novel downstream targets and examine genome-wide
changes in expression in response to the induction of E2A
homodimers, an RNA-seq approach was chosen. One aim of this
approach was to identify factors that mediate the ability of E2A to
upregulate Sox1. Expression of Sox1 transcript was robustly
upregulated by 18 h compared with the corresponding no dox
control, whereas expression of Sox1 protein was first detected at
24 h (Fig. S6B,C). Based on these observations we performed
Fig. 3. E2A−/− and E2A−/−HEB−/− ESCs self-renew normally but display defects in early neural commitment. (A) Immunostaining of WT, E2A−/− and
E2A−/−HEB−/− knockout ESCs stained for pluripotency markers in LIF/serum (L/S). (B) qRT-PCR analysis of parental and knockout cell lines in L/S and
differentiated in N2B27 over 5 days. Expression values are normalised to the housekeeping gene Sdha. Data are mean±s.d., n=3 biological replicates.
*P<0.05, **P<0.01 and ***P<0.001, two-tailed paired Student’s t-test. (C,D) Cells differentiated in N2B27 for 5 days stained for Oct4 and Sox1 (C), or the neuronal
marker Tuj1 and the mesendodermal marker T-brachyury (T-bra). Scale bars: 30 µm.
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RNA-seq analysis at 0 h (no dox), 18 h and 24 h timepoints in
triplicate to capture changes in genes acting upstream of Sox1. We
found that of the 335 genes that were upregulated at 18 h compared
with 0 h, 291 remained significantly upregulated at 24 h, whereas
112 out of the 174 genes downregulated at 18 h remained
downregulated at 24 h (Fig. 4A).
Fig. 4. Global transcriptome
profiling by RNA-seq reveals E2A
homodimers specifically
upregulate neural lineage markers.
(A) Differentially expressed genes in
each comparison according to a
minimum threshold of log2 fold-
change of 2 and a maximum FDR of
0.05. Proportional Venn diagrams
illustrate the overlap of differentially
expressed genes between
timepoints. (B) GO analysis of the top
50 upregulated genes at 24 h.
(C) Heatmap of the top 50 genes
upregulated at 24 h. (D) Mean FPKM
(fragments per kilobase per million
reads mapped) RNA-seq expression
values for selected genes at 0 h, 18 h
and 24 h. Data are mean±s.d., n=3
biological replicates.
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E2A homodimers specifically promote neural lineage
commitment
Gene ontology (GO) analysis of genes upregulated at 24 h revealed
an enrichment for terms associated with neural differentiation,
including ‘nervous system development’, ‘neurogenesis’ and
‘generation of neurons’ (Fig. 4B). Further interrogation of the
RNA-seq data highlighted an upregulation of neural lineage-
associated genes, including Foxd4 [log2 fold-change (logFC) 5.7;
false discovery rate (FDR) 0.0003], Sox1 (logFC 2.8; FDR 0.003),
Neurog3 (logFC 3.1; FDR 7.18E-05) and Neurod4 (logFC 4.4;
FDR 0.02) (Fig. 4C,D). In contrast, early markers of non-neural
lineages, such as T, Eomes, Gata4, Gata6 and Foxa2 were not
upregulated, suggesting that E2A homodimers specifically drive
neural lineage commitment in ESCs. We additionally observed an
upregulation of EMT-related genes, including Snai1, Snai2 and
Zeb2, but no detectable early downregulation of E-cadherin, which
was in line with our previous qRT-PCR analyses. We also found an
upregulation of Notch signalling components, including Dll1, Dll3
and the FGF target gene Hes6 (Koyano-Nakagawa et al., 2000;
Murai et al., 2007), and downregulation of Nodal pathway genes,
including the Nodal co-receptor Cripto (Tdgf1) and the Nodal target
gene Lefty2. Taken together, these data suggest that E2A homodimers
are able to dominantly induce a transcriptional programme associated
with the early stages of neural differentiation, although it remains
possible that additional factors might be required to enable cells to
progress through the later stages of neuronal differentiation.
E2A drives neural commitment by upregulating Foxd4 and
dampening Nodal signalling
The forkhead box TF Foxd4 is a likely candidate for mediating the
effect of E2A on neural differentiation. Foxd4 was identified by
RNA-seq as the most highly upregulated gene at 24 h following
E2A homodimer induction (Fig. 4C), and is required for neural fate
acquisition in mouse ESCs (Sherman et al., 2017). This is consistent
with our observation that Foxd4 is transiently upregulated at day 3 of
neural differentiation, before overt Sox1 expression, whereas E2A−/−
and E2A−/−HEB−/− cells fail to upregulate Foxd4 (Fig. 3B).
Alternatively, E2A could be modulating differentiation by
dampening Nodal activity. The Nodal pathway genes Cripto and
Lefty2 were found to be downregulated in response to E2A
induction (Fig. 4D). During gastrulation, the anterior epiblast fated
for neuroectoderm is ‘silent’ for Nodal signalling (Peng et al.,
2016), and inhibition of the pathway has been shown to promote
neural differentiation in both mouse and human ESCs (Vallier et al.,
2004; Watanabe et al., 2005; Camus et al., 2006). We found that
although Cripto and Lefty2 were rapidly downregulated and
maintained at basal levels during the differentiation of control cells,
they were progressively upregulated in E-protein knockout lines, with
a more dramatic effect evident in E2A−/−HEB−/− cells (Fig. 5A).
Based on these observations, we hypothesised that Foxd4 and/or a
dampening ofNodal signalling could explain howE2Acan drive neural
differentiation. To test this, we sought to determine whether ectopic
expression of Foxd4 or inhibition of Nodal signalling could rescue the
neural differentiation defect observed in E-protein knockout cells.
We first generated E2A−/− ESC lines that ectopically express
Foxd4. A plasmid encoding Foxd4 cloned upstream of an internal
ribosomal entry site (IRES)-puromycin resistance cassette, under
the control of a PGK promoter, was assembled and transfected into
E2A−/− cells. Foxd4 expression was assessed in undifferentiated
ESCs by qRT-PCR (Fig. S7A) and three clonal lines were chosen
for subsequent analyses (clones 3, 7 and 8). Ectopic expression of
Foxd4 was not sufficient to force neural differentiation of E2A−/−
ESCs cultured in LIF/serum, as assessed by Sox1 expression (Fig.
S7A). However, using quantitative immunostaining analysis, we
observed that when cells were placed under differentiation
conditions, ectopic expression of Foxd4 was able to partially
restore Sox1 expression in knockout cells (Fig. 5B,C; Fig. S7B;
Table S3) and to promote a large proliferation of the Oct4-
expressing cells present in the culture (Fig. 5B,C).
We then sought to test whether inhibition of the Nodal
pathway using SB431542 (SB43), which inhibits the activity of
TGF-β receptors (Inman et al., 2002), could restore neural
differentiation in E-protein knockout cells. We observed that
SB43 treatment increased the proportion of Sox1 expression
in control cells, and resulted in a strong upregulation of Sox1 in
E2A−/− and E2A−/−HEB−/− lines. When applied to cells also
ectopically expressing Foxd4, SB43 was able to effect a robust
differentiation response (Fig. 5B,C; Fig. S7B,C). Taken together,
these results suggest an additive effect of ectopic Foxd4 expression
and TGF-β pathway inhibition in restoring the differentiation
capacity of E2A−/− cells. We conclude that E2A homodimers
promote neural differentiation by upregulating Foxd4 while
dampening the activity of TGFβ ligands.
DISCUSSION
The key extracellular signalling pathways that inhibit differentiation
of ESCs are now well established (Haegele et al., 2003; Smith et al.,
2008; Ying et al., 2003a; Zhang et al., 2010). A considerable
amount of progress has also beenmade in elucidating the network of
TFs that control later aspects of mammalian neuronal specification
and differentiation (Imayoshi and Kageyama, 2014). Much less is
known, however, about the molecular processes that link these two
events at the earliest stages of neural differentiation. Recent work
has identified roles for TFs such as Zfp521, Oct6 and Zic1/2 as
intrinsic regulators of early neural differentiation (Kamiya et al.,
2011; Zhu et al., 2014; Sankar et al., 2016). However, although it
has been demonstrated that Oct6 is involved in the activation of
several neural fate-promoting genes (Zhu et al., 2014), Zfp521 and
Zic1/2 are more likely playing a role in consolidating, rather than
initiating, neural fate (Kamiya et al., 2011; Iwafuchi-Doi et al.,
2012). In this study, we sought to identify novel intrinsic regulators
of neural fate commitment in ESCs, and to elucidate the molecular
events unfolding downstream of the BMP signalling pathway
during this process.
The HLH transcription factor Id1 has previously been identified
as a key effector of the BMP pathway, and its overexpression has
been shown to block entry into the neural lineage and promote
differentiation to alternative fates (Ying et al., 2003a,b; Malaguti
et al., 2013). Although the function of Id proteins as dominant-
negative inhibitors of bHLH transcription factors is well
characterised in heterologous systems (Norton, 2000), it has not
previously been investigated whether Id1 could also be functioning
via this classical mechanism during neural commitment. Taken
together with the observation that E2A is the major binding partner
of Id1 in ESCs (Davies et al., 2013), we therefore hypothesised that
Id1 maintains pluripotency by sequestering E2A, thus preventing it
from forming functional homodimers or heterodimers that could
otherwise initiate a differentiation response.
Despite their widespread expression during embryogenesis
(Pérez-Moreno et al., 2001), a definitive role for Class I bHLH
TFs in early neural development has not been explored, with E-
proteins often relegated to simply being obligate dimerisation
partners for tissue-specific Class II bHLH factors. Single E-protein
knockouts in mice have also failed to uncover any robust
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neurodevelopmental deficiencies, and attempts to generate
E-protein compound knockouts to overcome the expected
problem of functional compensation between family members
have thus far been unsuccessful as even mice with only single
E-proteins knocked out do not survive beyond 2 weeks after birth
(Ravanpay and Olson, 2008). In Drosophila, however, loss of the
only Class I bHLH factor gene, daughterless, has been found to
result in neural differentiation defects (Caudy et al., 1988).
In this study we explored a role for E2A in neural fate
commitment. Generation of an endogenously tagged E2A-V5
Fig. 5. Combined Foxd4 expression and Nodal signalling inhibition rescues differentiation defect in E-protein knockout cells. (A) qRT-PCR analysis
of Nodal pathway gene expression in knockout and parental ESC line differentiation. Data are mean±s.d., n=3 biological replicates. *P<0.05, **P<0.01 and
***P<0.001, two-tailed paired Student’s t-test. (B) Immunostaining of parental and knockout cells at day 5 of differentiation ±10 µM SB43. Scale bars: 50 µm.
(C) Quantification of immunostaining of cells at day 5 of differentiation ±10 µM SB43 performed by quantitative image analysis. Data are themean values for three
biological replicates. A minimum of 8000 nuclei were scored per experiment. Data for all replicates are shown in Table S3.
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ESC line enabled us to define the expression of E2A from
pluripotency to the onset of differentiation on the single cell level.
Using a doxycycline-inducible system, we report that overexpression
of E2A is sufficient to promote commitment to the neural lineage in
ESCs, even under non-permissive culture conditions. Specifically,
we found that forced E2A homodimers, rather than E2A-bHLH
heterodimers, appear to drive this process, as the introduction of a
single amino acid change (C570A) into E2A to disrupt homodimer
stability, while still maintaining heterodimerisation capacity
(Benezra, 1994), did ablate the ability of the forced homodimer to
promote Sox1 expression. These findings suggest that Id proteins
inhibit neural differentiation, at least in part, by suppressing
homodimerisation of E proteins: this would to our knowledge be
the first example of a physiological role for E2A homodimers outside
of the context of B-cell specification (Shen and Kadesch, 1995). It
would be interesting to test this further by investigating whether E2A
forced homodimers render neural differentiation resistant to the anti-
neural effects of Id proteins, and whether introducing a C570A
mutation into endogenous E2A recapitulates the neural defects seen
in E2A null cells.
Interestingly, we also found that overexpression of E2Awas able
to drive upregulation of its own negative regulator, Id1, consistent
with previous descriptions of a Class I/Class V HLH feedback loop
in Drosophila, in which overexpression of the E-protein
daughterless causes transcriptional upregulation of the Id protein
Extra macrochaetae (Bhattacharya and Baker, 2011). We recognise
that our forced homodimerisation of E2A is likely to disrupt this
negative-feedback loop, and that this effect might help amplify the
pro-neural activity of E2A homodimers.
The findings from the gain-of-function assays were further
supported by data from the loss-of-function studies. Generation of
novel E2A−/− and E2A−/−HEB−/− ESC lines highlighted that
although knockout cells were able to self-renew normally, they were
not able to differentiate efficiently. Additionally, although knockout
cells were able to downregulate Nanog, they maintained relatively
high expression of the epiblast markers Fgf5 and Oct4. This
suggests that although knockout cells are able to navigate the exit
from pluripotency efficiently, they fail to complete the proposed
second stage of neural lineage commitment involving the transition
from epiblast-like cells to neuroectoderm-like cells (Zhang et al.,
2010). The observation that E2A−/−HEB−/− cells displayed a more
pronounced neural differentiation defect suggests that HEB is,
indeed, able to at least partially compensate for the loss of E2A in
this context. This is in line with previous studies that have
demonstrated that HEB is able to functionally replace E2A during
B-cell commitment (Zhuang et al., 1998), highlighting the
extent of redundancy between E-protein family members.
That E2A−/−HEB−/− cells also appear to preferentially
upregulate markers of mesendodermal lineages, including T and
Eomes, is a potentially interesting topic of investigation for
future studies, especially considering that HEB (and E2A) have
previously been implicated in promoting mesendodermal lineage
specification, both in Xenopus and in human ESCs (Yoon et al.,
2011; Li et al., 2017).
In this study, we identified Foxd4 as a key gene strongly
upregulated in response to forced E2A homodimers, positioning it
upstream of Sox1 expression during neural commitment. These data
are in line with recent observations also made in ESCs (Sherman
et al., 2017), and with the reported expression of Foxd4 in the mouse
neuroectoderm at E7.5 (Kaestner et al., 1995). The Xenopus
homologue of Foxd4, Foxd4l1 (previously Foxd5), has a well-
established role as part of a broader network of neural fate stabilising
factors (Yan and Moody, 2009), and it has been shown to expand
the population of progenitor cells in the immature neuroectoderm,
while repressing the transcription of genes associated with neural
differentiation (Sullivan et al., 2001). A potential role for
Foxd4 in maintaining neuroectodermal cells in a proliferative
non-differentiating state, therefore, might also explain the large
proliferation of Oct4+ cells we observed when Foxd4 was
ectopically expressed in E2A−/− cells.
We also reported that components of the Nodal signalling
pathway were downregulated upon the overexpression of E2A
homodimers, and conversely upregulated during the differentiation
of E-protein knockout cells. Interestingly, E2A has also been shown
to repress the transcription of lefty in Xenopus, with knockout of
E2A causing upregulation of lefty and a subsequent failure in
mesendodermal fate specification (Wills and Baker, 2015). We
propose that E2A could be playing a similar role to repress Nodal
signalling in mouse pluripotent cells, but during neural fate
commitment – a process in which the inhibition of Nodal
signalling is already known to be important in both mouse and
human pluripotent cells (Watanabe et al., 2005; Vallier et al., 2009).
Given that the inhibition of Nodal also promotes neural
differentiation of human pluripotent cells (Vallier et al., 2004;
Chambers et al., 2009) and that E2A regulates lefty in human cells
(Yoon et al., 2011), it seems likely that E2A might also drive neural
differentiation of human pluripotent cells, although this remains to
be tested. It is likely that E2A has multiple downstream effectors in
mammalian cells, as it does in Xenopus (Wills and Baker, 2015), but
our rescue experiments suggest that the inhibition of Nodal and the
activation of Foxd4 are key effectors that explain the ability of E2A
to drive neural differentiation. In summary, we propose that E2A
plays an instructive, rather than passive, role in promoting neural
fate commitment in pluripotent cells by promoting the transcription
of neural lineage genes while simultaneously suppressing the Nodal
signalling pathway.
MATERIALS AND METHODS
Mouse ESC culture and neural differentiation
E14tg2αmouse ESCs were used as wild-type cells. All cell lines used in this
study were screened for mycoplasma contamination. ESCs were maintained in
Glasgow minimum essential medium supplemented with β-mercaptoethanol,
non-essential amino acids, glutamine, pyruvate, 10% fetal calf serum (FCS)
and 100 units/ml LIF on gelatinised tissue culture flasks (Smith, 1991).
Monolayer neural differentiation was performed as described by Pollard et al.
(2006). Briefly, ESCs were washed in Dulbecco’s modified eagle medium
(DMEM)/F12 to remove all traces of serum and plated at 1×104 cells/cm2 in
N2B27 medium on gelatinised tissue culture plates. N2B27 consists of a 1:1
ratio of DMEM/F12 and Neurobasal media supplemented with 0.5% N2,
0.5% B27, L-glutamine and β-mercaptoethanol. For Nodal signalling
inhibition experiments, cells were seeded in N2B27 supplemented with
10 µM SB431542.
CRISPR/Cas9 epitope tagging of ESC lines
Guide RNAwas manually designed to introduce the V5 tag into the 3′UTR
of E2A based on the annotation of the final coding exon and the 3′ UTR
sequence. A ∼200 bp sequence around the stop codon was used as an input
for guide RNA design using either crispr.mit.edu or crispor.tefor.net web-
based design tools. High-scoring guide RNAs were chosen based on
minimal predicted off-target cleavage events, and having a cut site within
the 3′ UTR, preferably within 10 bp of the stop codon. For ssODN design,
the V5 tag sequence was flanked by ∼75 bp homology arms and a PAM-
blocking mutation (NGG>NGC) was introduced into the 3′ UTR sequence
to prevent re-cutting of donor DNA by Cas9. Ribonucleoprotein (RNP)
complexes were assembled as described by Dewari et al. (2018). Briefly,
crRNA and tracrRNA oligos were mixed in equimolar concentration, heated
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at 95°C for 5 min and allowed to cool to room temperature to anneal.
Recombinant Cas9 protein (10 μg) was added to the annealed cr/tracrRNAs
to form the RNP complex, which was incubated at room temperature for
20 min and stored on ice until electroporation. ssODN (30 pmol) was added
to the RNP complex immediately before electroporation. ESCs (5×104)
were transfected using the 4D Amaxa nucleofection system (Lonza) using
the optimised program CA-210. Following transfection, cells were
transferred into a six-well plate and allowed to recover for 3 to 5 days in
ESCmedia. Clonal cell lines were isolated from bulk populations by manual
colony picking and were subsequently analysed for successful knock-in by
PCR genotyping, immunocytochemistry and Sanger sequencing of a
∼500 bp region spanning the target site.
Synthetic Alt-R crRNA, tracrRNA, ssODN Ultramer template DNA
oligonucleotides and recombinant Cas9 protein were manufactured by
Integrated DNATechnologies. Guide RNA and ssODNDNA sequences are
provided in Table S1.
Knockout ESC line generation
For generation of E2A−/− ESCs, guide RNAs were designed to target exon 3
of the E2A gene. Targeting was performed on the E2A-V5 cell line to
facilitate knockout line validation by loss of V5 signal. For generation of
E2A−/−HEB−/− double knockout ESCs, exon 9 of the HEB locus was
targeted in E2A−/− knockout cells (clone 9) in order to disrupt both HEBcan
and HEBalt splice variants. Guides were designed, assembled as RNPs
with recombinant Cas9 and transfected as detailed above. Knockouts
were verified by Sanger sequencing of targeted allele and western blot
analysis using mouse anti-V5 (1:1000; Thermo Scientific, R960-25) and
mouse anti-HEB (1:200; Santa Cruz Biotechnology, sc-28364)
antibodies. Experiments presented in the main text were performed
using E2A−/− clone 9 and E2A−/−HEB−/− clone 12.
Doxycycline-inducible E2A cell lines
The E47 monomer construct comprises an N-terminally FLAG-tagged
mouse E47 sequence. To generate the E47 forced homodimer construct, the
DNA sequence corresponding to the FLAG-tagged mouse E47 was tethered
at its C-terminus to the N-terminus of a second mouse E47 sequence with a
13-amino acid flexible linker sequence of TGSTGSKTGSTGS by
overlapping extension PCR (Malaguti et al., 2019). For generation of the
C570A homodimerisation-deficient cell lines, mutations were introduced
into both E47 sequences in the forced dimer construct using PCR site-
directed mutagenesis and verified by Sanger sequencing. Inducible cells
lines were generated using an inducible cassette exchange technique
(Iacovino et al., 2013). Cells were stimulated with 1 µg/ml doxycycline in all
experiments.
Generation of Foxd4 rescue lines
The full-length Foxd4cDNA sequence was cloned into a pPGK-IRES-
puromycin resistance plasmid. E2A−/− (clone 9) cells were transfected with
the resulting construct using the 4D Amaxa nucleofection device (Lonza)
and clonal lines were isolated by puromycin selection (1 μg/ml). Following
clonal line expansion, ESCs were characterised by qRT-PCR for Foxd4
expression.
Immunocytochemistry, western blot analysis and flow
cytometry
For immunocytochemistry, samples were fixed with 4% paraformaldehyde
for 10 min at room temperature and incubated with blocking buffer (PBS,
0.1% Triton X-100, 3% donkey serum) for 30 min at room temperature.
Primary antibodies were diluted in blocking buffer and incubated with cells
overnight at 4°C. After three washes with PBS, cells were incubated with
secondary antibodies conjugated with Alexa fluorophores (Life Technologies)
diluted 1:1000 in blocking buffer for 1 h at room temperature. For nuclear
counterstaining, cells were incubated with 1 µg/ml DAPI (Sigma-Aldrich) for
5 min following immunostaining. Cells were washed a minimum of three
times in PBS before imaging. For confocal imaging, cells were plated onto
glass coverslips, stained and mounted in ProLong Gold Antifade Reagent
(Life Technologies). Cells were either imaged on the Leica SP8 confocal
microscope or the Olympus IX-81 widefield microscope. All images were
analysed in Fiji. Primary antibodies used for immunocytochemistry
were: mouse anti-β-III-tubulin/Tuj1 (1:1000; BioLegend, MMS-435P), rat
anti-Nanog (1:200; Thermo Fisher Scientific, 14-5761-80), goat anti-Oct4
(1:200; Santa Cruz, sc-8628), mouse anti-Sox1 (1:200; BD Pharmingen,
560749), rabbit anti-Sox2 (1:200; Abcam, ab97959) and mouse anti-V5
(1:200-500; Thermo Fisher Scientific, R960-25). Secondary antibodies used
in immunostaining experiments were: donkey anti-mouse Alexa Fluor 488
(Thermo Scientific, A21202), donkey anti-mouse Alexa Fluor 568 (Thermo
Scientific, A10037), donkey anti-rabbit Alexa Fluor 488 (Thermo Scientific,
A21206), donkey anti-rabbit 568 (Thermo Scientific, A10042), donkey anti-
rat Alexa Fluor 488 (Thermo Scientific, A21208), donkey anti-rat Alexa Fluor
594 (Thermo Scientific, A21209) and donkey anti-goat Alexa Fluor 647
(Thermo Scientific, A21447).
For western blot analysis, cells were lysed in radioimmunoprecipitation
assay buffer+1× PMSF (Alpha Diagnostics). Protein lysate (20 μg) was run
on 4%-12%NuPAGEBis-Tris Gel (Novex) and transferred onto Amersham
Hybond ECL Nitrocellulose Membrane (GE Healthcare). Membranes were
blocked in 5% Amersham ECL Prime Blocking Agent (GE
Healthcare)+0.1% Tween 20 (Sigma-Aldrich) in PBS for a minimum of
1 h at room temperature. Membranes were incubated with primary antibody
overnight at 4°C, washed in PBS+0.1% Tween 20, incubated in horseradish
peroxide (HRP)-conjugated secondary antibody for 1 h at room temperature
and washed in PBS+0.1% Tween 20. Membranes were subsequently
incubated in Amersham ECL Western Blotting Detection Reagent (GE
Healthcare) or Amersham ECL Prime Western Blotting Detection Reagent
(GE Healthcare). Membranes were either used to expose Amersham
Hyperfilm ECL (GE Healthcare) and developed using a Konica SRX-101A
Medical Film Processor, or imaged using the Bio-Rad ChemiDoc system.
Primary antibodies used in the western blot analysis were mouse anti-β-III-
tubulin/Tuj1 (1:1000; Sigma-Aldrich, T5293), mouse anti-E2A (1:200;
Santa Cruz Biotechnology, sc-416,), mouse anti-FLAG (1:5000; Sigma-
Aldrich, F9291), mouse anti-HEB (1:200; Santa Cruz Biotechnology, sc-
28364,), mouse anti-Sox1 (1:1000; BD Pharmingen, 560749) and V5
(1:500-1:1000; Thermo Fisher Scientific, R960-25). Secondary antibodies
used were Amersham ECL Mouse IgG, HRP linked (GE Healthcare,
NA931V) and Amersham ECL Rabbit IgG, HRP linked (GE Healthcare,
NA934).
For flow cytometry analysis, cells were dissociated into a single cell
suspension in PBS+10% FCS. Cells were stained with rat anti-E-cadherin
(CD324), eFluor660-conjugated DECMA-1 (1:300; eBioscience, 50-3249-
82) and 100 ng/ml DAPI to stain dead cells. Flow cytometry was performed
on the BD Accuri C6 and analysis was performed using FlowJo software.
Quantification of immunostaining
Immunofluorescence was quantified by nuclear segmentation based on
DAPI signal and manual editing of segmentation results using Nessys
software, as detailed by Blin et al. (2019).
qRT-PCR
Total RNAwas isolated from cells using the Absolutely RNAMiniprep Kit
(Agilent). cDNA was generated using Moloney murine leukaemia virus
reverse transcriptase and random primers. Primers and UPL probes (Roche)
used are detailed in Table S2. All gene expression values were normalised to
the housekeeping gene Sdha.
RNA-seq
RNA was isolated from cells using the Absolutely RNA Miniprep Kit
(Agilent) and RNA quality was verified using an Agilent 2100 Bioanalyzer.
Subsequent cDNA library preparation, sequencing and bioinformatics
analysis, including differential gene expression analyses, were performed by
the Edinburgh Genomics facility. Library preparation was performed using
the TruSeq Stranded mRNA Library Prep Kit (Illumina) and libraries were
sequenced on the Illumina HiSeq4000. Reads were mapped to the mouse
genome GRCm38 from Ensembl and were aligned to the reference genome
using STAR (version 2.5.2b). Differential gene analysis was carried out with
edgeR (version 3.16.5). Differentially expressed genes were assigned based
on a minimum fold-change of two and a maximum FDR of 0.05. Gene
ontology analysis was performed on genes upregulated at 24 h using the
STRING database (Szklarczyk et al., 2017).
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Statistical analyses
qRT-PCR data are represented as mean±s.d. for a minimum of three
experimental replicates. Statistical significance was calculated using
Student’s t-tests for pairwise comparisons, or ANOVA with correction for
multiple comparisons for two or more samples. Statistically significant
differences are shown as follows: *P<0.05, **P<0.01 and ***P<0.001.
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Figure 1. Generation and validation of endogenously tagged E2A-V5 ES 
cell lines.  
(A) Schematic of exon targeting of E2A to generate tagged cell lines. V5 tag is shown in green, 
stop codon in red, and yellow arrow indicates location of the guide RNA (sgRNA) sequence.  
(B) Method used to knock in the V5 tag by nucleofection of a complexed ribonucleoprotein 
(RNP) comprised of recombinant Cas9 protein (rCas9) and guide RNA into wild-type ES cells.  
(C) PCR genotyping of derived clonal lines using primer pairs indicated by green and black 
arrows depicted in (A). Bands of correct size in clonal lines shown, compared to blank (H20), 
parental WT line, and bulk transfected population.  
(D) Sanger sequencing trace of correctly targeted E2A-V5 clonal lines, confirming correct in-
frame insertion of the  V5 tag. 
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Figure 2. Sox1 is not expressed when inducible cells are cultured in 
LIF/serum without dox induction.  
(A)  qRT-PCR analysis of dox-inducible E2A monomer and forced homodimer cells cultured 
in LIF/serum without dox. Expression values are normalised to day 0. Error bars 
represent mean +/-SD of 2 biological replicates.  
(B)  Immunocytochemistry of inducible forced homodimer cells cultured in LIF/serum 
without dox.  
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Figure 3. Wild-type and mutant forced homodimer cells. 
(A) Sequence of the helix-loop-helix (HLH) domain of wild-type E2A with Cysteine-570 residue 
in helix 1 highlighted in yellow.  
(B) Sanger sequencing trace of Cys>Ala (C570A) mutation introduced into both E2A monomer 
sequences in the forced homodimer construct to generate mutant forced homodimer inducible 
lines (C570A-1 and C570A-9).  
(C) Western blot analysis of wild type monomer, forced homodimer and mutant forced 
homodimer cell lines +/- 24h of doxycycline induction. Membrane was blotted using anti-FLAG 
to detect the transgene and B-tubulin was used as a loading control. 
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Figure 4. Validation of E-protein knockout lines  
(A) Structure of E2A and HEB loci. Red arrow indicates Cas9/sgRNA target site. (B) Western blot of 
E2AV5 Cl.74 (parental cell line) and three E2A knockout clones 2, 9 & 11 using anti-V5 antibody. 
E2A-V5=69kDa. B-tubulin was analysed as a loading control. (C) Immunostaining of WT, E2A-V5 
(parental) and E2A-/- clonal lines with anti-V5 antibody. Scale bar: 30 µm (D) Sanger sequencing of 
E2A-/- clones 2, 9 and 11. WT exon 3 and ssODN template DNA amino acid sequences shown with 
mutations highlighted in red. E2A-/-  clone 2 has biallelic knock-in of the stop codon-containing 
ssODN template sequence, clone 9 has two independently disrupted E2A alleles and clone 11 has 
heterozygous knock-in of the ssODN and a second non-homologous end joining (NHEJ)-disrupted 
allele. (E) Western blot of E2AV5 Cl74, E2A-/- clone 9 (parental) and E2A-/-HEB-/- clonal lines using 
anti-HEB antibody. HEB=85kDa. B-tubulin was analysed as a loading control. (F) Sanger sequencing 
of E2A-/-HEB-/- clones 12 and 27. Targeted WT exon 9 and ssODN template DNA amino acid 
sequences shown above, with mutations highlighted in red. E2A-/-HEB-/- clone 12 has biallelic knock-
in of the ssODN sequence, and clone 27 has two independently disrupted HEB alleles; one allele 
contains an 8 amino acid deletion, the other allele contains a premature stop codon. 
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E2A-/- Cl. 9 allele 2: ! MFPLPVANGKSRPASLHALSAPTVNPGLAS!
E2A-/- Cl. 11 allele 1: ! MFPLPVANGKSRPASPEPSLQAQVGLRGS!
E2A-/- Cl. 11 allele 2: ! MFPLPVANGKSRPASLG*EFGTQFAGS!
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E2A-/-HEB-/- Cl.12 allele 2! VYAPSANSD*EFLKYPYDVPDYADFNRESPSYPSPKPATSMFASTFFMQ!
E2A-/-HEB-/- Cl. 27 allele 1! VYAPS - - - - - - - - RESPSYPSPKPPTSMFASTFFMQ!
E2A-/-HEB-/- Cl. 27 allele 2! VYAPSPNSD*EFLKYPTMFQITLISTVNLLVTHLP!
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Figure 5. Transcriptional analysis of additional E-protein knockout 
clones. qRT-PCR analysis of two additional E2A-/- clones (clones 2 and 11) and one additional 
E2A-/-HEB-/- clone (clone 27) differentiated in N2B27. Relative expression values shown are the 
mean of three independent experiments for each clonal line.  
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Figure 6. Identifying a time frame for detection of early E2A homodimer 
response genes.  
(A) Flow cytometric analysis of the effect of overexpression of E2A monomers and homodimers on 
E-cadherin (E-cad) protein expression. WT ES cells are included as a control and were used in 
combination with unstained WT cells to define gates. Experiments were repeated twice and the data 
from replicates follow the same trend as displayed in the figure. (B) qRT-PCR analysis of cells 
following 12, 18 and 24 hours of E2A homodimer induction in LIF/serum. No dox controls are also 
shown. Error bars represent standard deviation of three biological experiments, which were used for 
subsequent RNA-sequencing analysis. (C) Immunostaining of cells during the 24h timecourse to 
assess transgene activation using an anti-FLAG antibody, and co-staining with anti-Sox1 and anti-
Oct4. White arrows highlight small number of cells that express Sox1 protein 24 hours post-induction. 
Scale bar: 50 µm  
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Figure 7. Analysis of additional clonal lines ectopically overexpressing Foxd4 
in an E2A-/- background.  
(A) qRT-PCR analysis of knockout and Foxd4 rescue cell lines in LIF/serum. Relative expression 
values shown are the mean+/-SD of three biological replicates. (B) Immunostaining of additional 
knockout and Foxd4 rescue cell lines differentiated in N2B27+/-SB43. (C) Quantification of 
immunostaining of cells at day 5 of differentiation +/- 10 uM SB43 performed by nuclear 
segmentation and quantitative image analysis. Shown are the mean values for three independent 
biological replicates. A minimum of 8000 nuclei were scored per experiment. Data for all replicates are 
shown in Supplementary table 3. Scale bar: 50 µm  
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able 1. CRISPR/Cas9 targeting guide RNA and ssODN template 
sequences. 
 
Cell line 
generated 
 
Component Sequence 
E2A-V5 
Guide  AGCCGTCACAGCTTCTTCGT 
ssODN 
 
GTCGGGGACCCACAGCTGGCCCTGTCAGCCGCCCA
CCCGGGCCTGGGTGAGGCCCACAACCCAGCCGGGC
ACCTGGGTAAGCCTATCCCTAACCCTCTCCTCGGTCT
CGATTCTACGTGAGCCGTCACAGCTTCTTCGTTGCAC
CAGCGACCACCATATCTCTGCCCGGGGTGCATCAGG
ACGGTTCTGGATGAG 
 
E2A-/-  
Guide TGCAAACTGGGTTCCCCCGA 
ssODN 
 
CCTGACTTTTCTCTGTCCCCACAGATGTTCCCGCTAC
CAGTGGCCAATGGGAAGAGCCGGCCCGGCTCGCTC
GGGTGAGAATTCGGAACCCAGTTTGCAGGCTCAGGT
AGGACTGAGGGGCTCTTGGGGGGGTGTTCATGGGG
ACGGTGGCGGAGA 
 
E2A-/-HEB-/- 
Guide CGGTTGAAATCGTCAGAATT 
ssODN 
 
TATGTAAGTAATACATTTGAATTAATTATCCTGTTTTGT
TTTAAGGTATATGCACCATCCGCAAATTCTGACTAGG
AATTCCTTAAGTACCCATACGATGTTCCAGATTACGCT
GATTTCAACCGTGAATCTCCTAGTTACCCATCTCCCA
AGCCAGCAACCAGTATGTTCGCTAGCACTTTCTTTAT
GCAAGGTAAGC 
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Table S2. qRT-PCR primers and probes  
 
 
Gene 
 
Forward primer 
 
Reverse primer 
 
UPL 
probe 
Cdh1  
(E-cadherin) ATCCTCGCCCTGCTGATT  
 
ACCACCGTTCTCCTCCGTA  
 
18 
Cdh2  
(N-cadherin) 
 
GCCATCATCGCTATCCTTCT  
 
 
CCGTTTCATCCATACCACAAA  
 
18 
 
Cripto 
(Tdgf1) 
 
GTTTGAATTTGGACCCGTTG GGAAGGCACAAACTGGAAAG 93 
E2A 
 
GTGGGCTCTGACAAGGAACT  
 
 
ACAGGTAGCGGGAACATCAT  
 
79 
 
Eomes 
 
 
ACCGGCACCAAACTGAGA 
 
AAGCTCAAGAAAGGAAACATGC 9 
Fgf5 
 
AAAACCTGGTGCACCCTAGA  
 
 
CATCACATTCCCGAATTAAGC  
 
29 
Foxd4 TGGAGATCAGACGGAAGAAGA  
 
GATCGCTCCAGGCACTTATG  
 
63 
Id1 TCCTGCAGCATGTAATCGAC  
 
GGTCCCGACTTCAGACTCC  
 
78 
 
Lefty2 
 
GCCCTCATCGACTCTAGGC AGCTGCTGCCAGAAGTTCAC 97 
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Nanog 
 
CCTCCAGCAGATGCAAGAA  
 
 
GCTTGCACTTCATCCTTTGG  
 
25 
Oct4 
 
GTTGGAGAAGGTGGAACCAA  
 
 
CTCCTTCTGCAGGGCTTTC  
 
95 
 
Pax3 
 
AAAAGGCTAAACACAGCATCG CAATATCGGAGCCTTCATCTG 110 
 
Sox1 
 
GTGACATCTGCCCCCATC  GAGGCCAGTCTGGTGTCAG  60 
 
SDHA 
 
CAGTTCCACCCCACAGGTA  TCTCCACGACACCCTTCTGT  71 
 
T-brachyury 
 
ACTGGTCTAGCCTCGGAGTG  TTGCTCACAGACCAGAGACTG  27 
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Table S3. Immunostaining quantification (associated with Figure 5) 
(A) Cells differentiated in N2B27 (B) Cells differentiated in N2B27+SB43 
 
 
 
(A) 
 
-SB43 
% Rep1 % Rep2 % Rep3 Mean % Standard deviation 
Parental 
Oct4-/Sox1+ 72.9 89.2 83.8 82.0 8.34 
Oct4+/Sox1- 1.8 0.0 1.5 1.1 0.98 
Oct4+/Sox1+ 6.2 3.1 5.2 4.8 1.60 
Oct4-Sox1- 19.1 7.7 9.5 12.1 6.13 
  E2A-/- 
Oct4-/Sox1+ 4.7 7.6 56.5 22.9 29.07 
Oct4+/Sox1- 40.3 45.6 3.9 30.0 22.68 
Oct4+/Sox1+ 3.1 18.2 12.1 11.1 7.59 
Oct4-Sox1- 51.9 28.6 27.5 36.0 13.76 
  E2A-/-HEB-/- 
Oct4-/Sox1+ 17.3 6.6 56.0 26.6 28.78 
Oct4+/Sox1- 33.4 69.6 2.8 35.3 33.95 
Oct4+/Sox1+ 3.3 3.3 6.8 4.4 3.91 
Oct4-Sox1- 46.1 20.5 34.4 33.7 14.03 
  E2A-/- +Foxd4 Cl.3 
Oct4-/Sox1+ 57.0 61.3 43.5 53.9 9.27 
Oct4+/Sox1- 25.5 1.0 0.9 9.1 14.19 
Oct4+/Sox1+ 11.1 21.4 16.7 16.4 5.15 
Oct4-Sox1- 6.4 16.3 38.9 20.5 16.64 
  E2A-/- +Foxd4 Cl.7 
Oct4-/Sox1+ 42.8 45.4 40.0 42.8 2.68 
Oct4+/Sox1- 7.1 7.7 7.0 7.3 0.38 
Oct4+/Sox1+ 8.6 17.7 28.8 18.4 10.12 
Oct4-Sox1- 41.5 29.1 24.1 31.5 8.96 
  E2A-/- +Foxd4 Cl.8 
Oct4-/Sox1+ 10.3 0.3 1.9 4.2 5.39 
Oct4+/Sox1- 21.5 67.6 64.8 51.3 25.83 
Oct4+/Sox1+ 5.6 6.4 16.4 9.5 6.00 
Oct4-Sox1- 62.5 25.8 16.9 35.1 24.19 
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(B) 
 
+SB43 
% Rep1 % Rep2 % Rep3 Mean % Standard deviation 
Parental 
Oct4-/Sox1+ 93.1 99.3 97.7 96.7 3.18 
Oct4+/Sox1- 0.0 0.0 0.0 0.0 0.00 
Oct4+/Sox1+ 0.0 0.7 1.1 0.6 0.56 
Oct4-Sox1- 6.9 0.0 1.2 2.7 3.66 
  E2A-/- 
Oct4-/Sox1+ 73.1 65.0 93.9 77.3 14.88 
Oct4+/Sox1- 3.8 0.4 0.0 1.4 2.09 
Oct4+/Sox1+ 3.9 4.9 1.7 3.5 1.63 
Oct4-Sox1- 19.2 29.7 4.4 17.8 12.70 
  E2A-/-HEB-/- 
Oct4-/Sox1+ 73.5 63.5 97.8 78.2 17.19 
Oct4+/Sox1- 0.0 0.2 0.0 0.1 0.09 
Oct4+/Sox1+ 1.7 1.9 1.3 1.7 1.19 
Oct4-Sox1- 24.7 34.4 0.9 20.0 16.92 
  E2A-/- +Foxd4 Cl.3 
Oct4-/Sox1+ 82.8 85.1 96.7 88.2 7.44 
Oct4+/Sox1- 0.0 0.0 0.0 0.0 0.00 
Oct4+/Sox1+ 3.6 1.5 2.6 2.6 1.04 
Oct4-Sox1- 13.5 13.4 0.6 9.2 7.40 
  E2A-/- +Foxd4 Cl.7 
Oct4-/Sox1+ 85.1 94.4 97.0 92.2 6.27 
Oct4+/Sox1- 0.0 0.0 0.0 0.0 0.00 
Oct4+/Sox1+ 1.8 0.6 3.0 1.8 1.16 
Oct4-Sox1- 13.1 5.0 0.0 6.0 6.60 
  E2A-/- +Foxd4 Cl.8 
Oct4-/Sox1+ 76.3 95.6 97.0 89.6 11.58 
Oct4+/Sox1- 0.0 0.0 0.0 0.0 0.00 
Oct4+/Sox1+ 0.0 2.3 3.0 1.8 1.58 
Oct4-Sox1- 23.7 2.1 0.0 8.6 13.14 
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